Does papaverine cause endothelial injury in clinically relevant doses?
Joshi
S
S
Young
W L
WL
Pile-Spellman
J
J
D000818:Animals; D001921:Brain / Q000098:blood supply*; D004305:Dose-Response Relationship, Drug; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000473:pathology; D006801:Humans; D007261:Infusions, Intra-Arterial; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D010208:Papaverine / Q000008:administration & dosage / Q000009:adverse effects*; D051381:Rats; D012307:Risk Factors; D013345:Subarachnoid Hemorrhage / Q000150:complications; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects*
D014665:Vasodilator Agents; D010208:Papaverine